Pfizer and Flagship Pioneering are turning to autoimmune disease as the sixth plank of their multibillion-dollar, 10-program ...
Pfizer and Flagship Pioneering have entered into an agreement aimed at discovering potential selective inhibitors for ...
Pfizer (PFE) and Pioneering Medicines, Flagship Pioneering’s in-house drug discovery and development unit, announced an agreement to discover ...
One of the most promising aspects of AI and its integration into the pharmaceutical industry is the technology’s potential to discover new molecules and potential therapies. Pfizer is partnering with ...
Charles River Laboratories International, Inc. CRL and Valo Health, Inc. recently announced an advanced product candidate for the treatment of different forms of lupus and other autoimmune ...
Charles River Laboratories International, Inc. CRL and Valo Health, Inc. recently announced an advanced product candidate for the treatment of different forms of lupus and other autoimmune indications ...
Charles River Laboratories International, Inc. CRL and Valo Health, Inc. recently announced ... Institute for Advanced Biological Imaging. The partnership focuses on developing new technologies ...
Zacks Investment Research on MSN4d
Charles River & Valo Health's Logica Identifies New Lupus Drug CandidateCharles River Laboratories International, Inc. CRL and Valo Health, Inc. recently announced an advanced product candidate for the treatment of different forms of lupus and other autoimmune indications ...
The announcement sparked speculation that a number of health companies would be interested in buying the Pfizer business. These include GlaxoSmithKline, though it is already looking to buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback